Hydrix LimitedASX: HYD

AngelMed completes its first USA commercial Guardian implant

· Issued by Hydrix Limited

Filed with ASX · · 2 pages · English

The outpatient procedure was successfully performed last week by cardiac electrophysiologist and cardiologist Dr. Andrew J. Kaplan of Cardiovascular Associates of Mesa in Mesa, Arizona. Dr. Kaplan is a pioneer of new cardiac technologies and has played a significant role in The Guardian's commercialisation. The procedure marks The Guardian's first use following recent FDA approval. Indicated for a

Hydrix Limited on 6ix

Story so far

Earlier from Hydrix

Later from Hydrix

All Hydrix news releases